Biomarker Testing in Lung Cancer Treatment, Monitoring Progression & Managing Resistance (part 2)

In Part 2 of this series, Leah Phillips continues her conversation with Dr. Ben Creelan and Dr. Jhanelle Gray from Moffitt Cancer Center. This episode transitions from the basics of diagnosis to the practical application of biomarker testing throughout the entire patient journey.Our experts discuss how molecular profiles determine the choice between oral targeted therapies (TKIs) and traditional chemotherapy, and the impact of these options on patient quality of life.00:00 Introduction to Biomarker Testing in Lung Cancer02:13 The Role of Biomarkers in Treatment Decisions 05:07 Understanding Repeat Biomarker Testing 07:20 Managing Resistance Mutations and Treatment Adjustments 10:10 The Importance of Clinical Trials 12:38 Advancements in Targeted Therapies15:22 The Future of Biomarker Testing and Patient EmpowermentThis episode is proudly sponsored by Nuvation Bio